ORACLE Trademark
ORACLE is a USPTO trademark filed by LEICA BIOSYSTEMS MELBOURNE PTY LTD.. Status: Registered.
Prosecution Summary
**Trademark Summary** The standard character mark **ORACLE** covers goods in International Class 005, including DNA and RNA in situ hybridisation probes, antibodies, human cells, reagents and stains for detecting probes and antibodies, all for medical diagnostic use, along with classifications in domestic classes 006, 018, 044, 046, 051, and 052. It is currently **registered** on the Principal Register and was **renewed** for ten years on **July 11, 2019**. The owner is **Leica Biosystems Melbourne Pty Ltd.**, an Australian company that acquired rights from original applicant Vision Biosystems Pty Ltd. **Recent Activity** Filed on September 13, 2007, with priority claimed from an Australian application filed March 16, 2007, the mark was published for opposition on April 14, 2009, and
Trademark Facts
| Mark | ORACLE |
|---|---|
| Serial Number | 77279189 |
| Registration Number | 3645469 |
| Status | Registered |
| Filing Date | 2007-09-13 |
| Registration Date | 2009-06-30 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | LEICA BIOSYSTEMS MELBOURNE PTY LTD. |
| Attorney of Record | Jessica G. McDonald |
| Prosecution Events | 49 |
| Latest Event | ARAA on 2025-10-10 |
Goods & Services
[ DNA and RNA In Situ Hybridisation probes; ] antibodies; human cells; reagents and stains for detecting presence of probes and antibodies; all of the foregoing for medical diagnostic use